Both in Diagnostics
Insight Molecular Diagnostics vs Achieve Life Sciences
Over the past year IMDX returned −56.0% and ACHV returned +37.5%; their daily moves had a correlation of 0.16.
IMDX −56.0% ACHV +37.5%Growth of $1, one year, split-adjusted
| Metric | IMDX | ACHV |
|---|---|---|
| Price | $2.74 | $6.73 |
| Market cap | $89.7M | $693.9M |
| Today | −4.20% | +1.82% |
| 1 month | −25.3% | −4.0% |
| 6 months | −40.2% | +47.6% |
| Year to date | −63.5% | +35.4% |
| 1 year | −54.4% | +31.4% |
| Revenue growth (YoY) | −53.9% | — |
| Gross margin | 65.7% | — |
| Net margin | −4711.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 53.7× | — |
| Net cash | $17.8M | $172.4M |
| Dividend yield | — | — |
| Volatility (60d) | 95.6% | 60.1% |
| Short % of float | 3.7% | 28.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).